06. Autoimmune bullous diseases

Clinical and histological features of dipeptidyl peptidase-4 inhibitor related bullous pemphigoid

Ágnes Kinyó, Anita Hanyecz, Zsuzsanna Lengyel, Dalma Várszegi, Csaba Gyömörei, Endre Kálmán, Tímea Berki, Rolland Gyulai

An Indian experience of disease persistence and relapses in pemphigus and pemphigoid following Rituximab (biosimilar) therapy.

Mahendra Kura, Veeral Aliporewala

GLIPTIN-ASSOCIATED BULLOUS PEMPHIGOID AND THE EXPRESSION OF DIPEPTIDYL PEPTIDASE-4/CD26 IN BULLOUS PEMPHIGOID

Outi Lindgren, Outi Varpuluoma, Jussi Tuusa, Jorma Ilonen, Laura Huilaja, Nina Kokkonen, Kaisa Tasanen

Low dose Rituximab in Pemphigus – Study of 19 patients

Shrichand Parasramani

The Presence of Autoantibodies Prior to Clinical Diagnosis in Pemphigus Diseases

Alexandra Rosenberg, Meagan Simpson, Jon Meyerle

Dupilumab for the Treatment of Recalcitrant Bullous Pemphigoid

Gaurav Singh, Tejas Patel

Paraneoplasteic pemphigus as the first manifestation of T-cell lymphoblastic lymphoma in a child

Yuanyuan Xiao, Zigang Xu, Junmei Zhang, Tongxin Han, Libing Fu